A475960 Share Price Performance
₩24,800.00
14730.00 (146.28%)
Price ₩24,800.00
Share Price₩24,800.00
A475960 Community Narratives
There are no narratives available yet.
Recent A475960 News & Updates
No updates
Tomocube, Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -653.65
- Gross Margin
- 59.63%
- Net Profit Margin
- -160.96%
- Debt/Equity Ratio
- 0%
Tomocube, Inc. Competitors
About A475960
- Founded
- 2015
- Employees
- n/a
- CEO
- WebsiteView website
Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to accommodate both adherent and suspension cells; TomoChamber, a stage-top incubator designed for long-term live cell imaging; TomoPlate, an active vibration isolation system that enables users to capture images in a stable environment; and vessel holders, environmental controllers, and 3D controllers. The company was founded in 2015 and is headquartered in Daejeon, South Korea.
South Korean Market Performance
- 7 Days: -2.0%
- 3 Months: 20.9%
- 1 Year: 26.1%
- Year to Date: 28.6%
Over the last 7 days, the market has dropped 2.0%, driven by pullbacks in the Materials and Information Technology sectors of 7.0% and 1.3%, respectively. As for the longer term, the market has actually risen by 26% in the last year. Earnings are forecast to grow by 22% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading